Dysregulated COMT Expression in Fragile X Syndrome

Kagistia Hana Utami1,2, Nur Amirah Binte Muhammed Yusof1, Marta Garcia-Miralles1,3

  • 1Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research, Singapore (A*STAR), 8A Biomedical Grove, Immunos, Level 5, Singapore, 138648, Singapore.

Neuromolecular Medicine
|September 8, 2023
PubMed
Summary

Fragile X syndrome (FXS) neurons show reduced catechol-O-methyltransferase (COMT) expression, impacting dopamine signaling. Targeting catecholamine metabolism may help manage FXS neuropsychiatric symptoms.